entertainment -WSS

entertainment

author：focus 2025-09-10 10:57:31 - browse：7

DENVER — He could have been a rock star, a religious icon, the way ecstatic applause from thousands of attendees greeted the man dressed in a crisp, all-white suit as he strode onto a backlit stage. He was neither. This was Rick Doblin, the founder and evangelist of a movement to legalize psychedelic MDMA and bring the drug into mainstream medicine.

The scene in a Denver conference hall last week was a world away from the first conference Multidisciplinary Association for Psychedelic Studies (MAPS) held in 1990, when Doblin spoke alongside Timothy Leary — the ex-Harvard professor who popularized the phrase “turn on, tune in, and drop out.” That was just a few years after MDMA, also known as ecstasy, was criminalized, deemed a Schedule 1 drug “of no medical use.”

Now, as MAPS nears its goal of winning Food and Drug Administration approval for MDMA as a treatment for post-traumatic stress disorder, the perpetually smiling and energetic Doblin is basking in the adoration from both legions of “psychonauts” and unlikely yet powerful allies. “I literally love Rick Doblin,” the conservative Republican and former Texas governor Rick Perry told the audience in Denver.

It was a seemingly triumphant occasion. But even as Doblin is in sniffing distance of his lifelong quest, his once counter-cultural organization is grappling with the pressures of having to operate in the capitalist pharmaceutical sphere. MAPS was founded in 1986 as a nonprofit with deep-seated ideals. Doblin developed an “anti-patent” strategy, putting discoveries in the public domain so they couldn’t be claimed as intellectual property. He raised money to fund clinical trials of MDMA from like-minded wealthy donors.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Childhood vaccination ad campaign launches in the U.K.

WSS

General Catalyst, Summa Health deal will turn on physician buy

The real point of Kenneth Smith’s execution by nitrogen gas

ARCH Venture Partners is raising $3 billion for a life sciences fund

CDC panel: People 65 and older should get a Covid spring booster shot

Readout Newsletter: GSK, Viking Therapeutics, mifepristone news

ARCH Venture Partners is raising $3 billion for a life sciences fund

hotspot

entertainment

Wikipedia

Novavax promises a turnaround & Lilly roils the obesity market

Study fuels hope CAR

At least 13 dead in Texas as scorching temps continue

Medicare isn't yet testing food as medicine

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Covid misinformation case heads to Supreme Court

ChatGPT in medicine: STAT answers readers' burning questions

Quicker fix for pulse oximeters urged during FDA public meeting

Medical leaders decry Supreme Court decision on affirmative action

Cognito secures funding to test medical device for Alzheimer's

hotspot

Study fuels hope CAR

5 ways to address the shortage of health care workers

CDC advisory group OKs chikungunya vaccine

5 ways to address the shortage of health care workers

Woodcock on FDA’s accelerated approval and her next chapter

Medicare drug price negotiation’s day in court

Wikipedia

hotspot

hotspot

hotspot